Assessing the Emergence of Resistance: The Absence of Biological Cost In Vivo May Compromise Fosfomycin Treatments for P. aeruginosa Infections

Title
Assessing the Emergence of Resistance: The Absence of Biological Cost In Vivo May Compromise Fosfomycin Treatments for P. aeruginosa Infections
Authors
Keywords
Pseudomonas aeruginosa, Antibiotic resistance, Antibiotics, Mouse models, Inflammation, Respiratory infections, Bacterial biofilms, Mutant strains
Journal
PLoS One
Volume 5, Issue 4, Pages e10193
Publisher
Public Library of Science (PLoS)
Online
2010-04-16
DOI
10.1371/journal.pone.0010193

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now